tert-butyl 2,2-dimethylpiperazine-1-carboxylate hydrochloride | 1624260-26-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: tert-butyl 2,2-dimethylpiperazine-1-carboxylate hydrochloride
• 英文别名: tert-Butyl 2,2-dimethylpiperazine-1-carboxylate hydrochloride；tert-butyl 2,2-dimethylpiperazine-1-carboxylate;hydrochloride
• CAS: 1624260-26-9
• 化学式: C₁₁H₂₂N₂O₂*ClH
• 分子量: 250.769
• InChiKey: QIEBQSDOJMXWNN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.03
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  41.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl 2,2-dimethylpiperazine-1-carboxylate hydrochloride 在 盐酸 、 palladium diacetate 、 caesium carbonate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 作用下， 以 1,4-二氧六环 、 甲苯 为溶剂， 反应 8.0h， 生成 5-(3,3-dimethylpiperazin-1-yl)pyrimidine dihydrochloride
  参考文献：
  名称：

  [EN] BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY
  [FR] COMPOSÉS HÉTÉROARYLE BICYCLIQUES UTILES EN TANT QU'INHIBITEURS DE LA VOIE DE SIGNALISATION PAR-2

  摘要：

  式I的化合物，其中变量如本文所定义，并且其药学上可接受的盐可用作PAR-2信号通路的抑制剂。式I的化合物和包含这些化合物的药学上可接受的组合物可用于治疗各种疾病、疾病和症状。

  公开号：

  WO2016154075A1

文献信息

• [EN] PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS<br/>[FR] PYRIMIDOPYRIMIDINONES UTILES COMME INHIBITEURS DE LA WEE-1 KINASE
  申请人：ALMAC DISCOVERY LTD

  公开号：WO2015092431A1

  公开（公告）日：2015-06-25

  The present invention relates to compounds that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer.

  本发明涉及一类可用作Wee-1激酶活性抑制剂的化合物。本发明还涉及包含这些化合物的药物组合物以及使用这些化合物治疗癌症的方法和治疗癌症的方法。
• PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS
  申请人：ALMAC DISCOVERY LIMITED

  公开号：US20160318936A1

  公开（公告）日：2016-11-03

  The present invention relates to compounds that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer.
• BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：US20180057505A1

  公开（公告）日：2018-03-01

  The compounds of formula I, wherein the variables are as defined herein, and pharmaceutically acceptable salts thereof are useful as inhibitors of the PAR-2 signaling pathway. The compounds of formula I and pharmaceutically acceptable compositions comprising such compounds can be employed for treating various diseases, disorders, and conditions.
• US9850247B2
  申请人：——

  公开号：US9850247B2

  公开（公告）日：2017-12-26